<%@ page language="java" import="java.util.*" pageEncoding="UTF-8"%>
<%@ include file="../common/init.jsp"%>

<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<title>The best effort to ensure your antibody success</title>
<meta name="keywords" content="antibody insurance, successful antibody development" />
<meta name="description" content="AbInsure program is designed to provide a solution for failed projects so every protein will have our best effort for successful antibody development." />
</head>
<body>
	<div class="localbar">
		<li><a href="<%=home%>" style="color: white">Home</a> > AbInsure</li>
	</div>
	<div class="contentbox_new">
		<div class="tab"></div>
		<div class="field">
			<a class="h1">AbInsure&#8482;- The best effort to ensure your antibody success. </a>
			
			<p>
				Despite that our library approach (used throughout in our product series, including pre-made antibody series <a href="<%=path%>/abx_overview.html" target="_blank">AbX&#8482;</a>, pre-designed library series <a href="<%=path%>/abstop_overview.html" target="_blank">AbStop&#8482;</a>, custom antibody series <a href="<%=path%>/seal_overview.html" target="_blank">SEAL&#8482</a>; and <a href="<%=path%>/urgentmab_overview.html" target="_blank">UrgentMabs&#8482;</a>) has proven to greatly reduce the
					risks and uncertainties of antibody development, there will always be antibodies that fail to work for specific proteins or end-uses. AbInsure program is designed to provide a solution for failed projects so every protein will have our best effort for successful antibody development. 
			</p>
			
			<p>
				<img src="<%=path%>/res/img/abmart/abinsurance_figure_1.png" />
			<center style="font-weight: italic">Figure 1. AbInsure&#8482; service process and options</center>
			</p>
			
			<p>Following our recommendation, you will be automatically enrolled into the AbInsure&#8482; once you purchase a product from any of our series. If none of the purchased antibodies works in the recommended end-uses (see our application guide for help on how to use the antibodies), the AbInsure&#8482; program offers the following options for you to consider (Figure 1):</p>
			<div class="contentbox_newp">
				<div>
					<b>Option 1:</b>
				</div>

				<p>Risk-free re-development Since our first-time product recommendations need to balance your cost (is affordable) and the chance of being successful (a good chance to work), there is room for more aggressive antibody development – the approach we will take for re-developing antibodies for the failed project. That means more redundant protein coverage and bigger hybridoma library (broader affinity and epitope coverage).
				<p>Many failed p rojects have been made successful by our re-development effort, which is offered free by the AbInsure&#8482; program. You will only need to pay a pre-agreed cost (target and antibody end-use dependent, each target will need to be analyzed and determined (Table 1) to re-start the project. Once the new antibodies (0.1mg of each antibody for testing) work in your experiments, you will pay agreed cost minus 30% of the purchasing price of the original AbInsure&#8482; product
					for receiving the full package of successful antibodies (0.5mg each) (Table 2).</p>
				<p>In summary, risk-free re-development covered by the AbInsure&#8482; allows you to enjoy our best effort for developing successful antibodies against your protein targets, at a greater discount yet better assurance.</p>
				

				<center style="font-weight: italic">Table 1. Price range for the re-development projects, depending on the target and end-use</center>
				<table width="80%" border="1px solid" class="h40">
					<tr>
						<td width="15%" height="84px" rowspan=2 valign="bottom" align="center"><a href="<%=path%>/abtech.html#abclass" target="_blank">AbClass&#8482;</a></td>
					</tr>
					<tr>

						<td rowspan=2>
							<table width="100%" border="0">

								<tr>
									<td colspan=3 align="center">End-use<br>(<a href="<%=path%>/abtech.html#appclass" target="_blank">AppClass&#8482;</a>)
									</td>
								</tr>
								<tr>
									<td align="center" width=33% style="border-right: 1px solid; border-bottom: 1px solid; border-top: 1px solid">
										<table width=100% border=0>
											<tr>
												<td align="center">WB<br>(I)
												</td>
												<td align="center">IF<br>(II)
												</td>
												<td align="center">IHC<br>(II)
												</td>
											</tr>
										</table>
									</td>
									<td align="center" width=33% style="border-right: 1px solid; border-bottom: 1px solid; border-top: 1px solid"><table width=100% border=0>
											<tr>
												<td align="center">IP/ChIP<br>(III)
												</td>
												<td align="center">ELISA<br>(Dx)
												</td>
												<td align="center">FCM<br>(Dx)
												</td>
											</tr>
										</table></td>
									<td align="center" width=33% style="border-bottom: 1px solid; border-top: 1px solid">Functional<br>(Tx)
									</td>
								<tr>
								<tr>
									<td align=center>$3,000-4,000<br> $4,000-5,000<br> $5,000-7,000
									</td>
									<td align=center>$4,000-5,000<br> $5,000-7,000<br> $7,000-10,000
									</td>
									<td align=center>To be determined case by case</td>
								</tr>
							</table>
						</td>
					</tr>
					<tr>
						<td align=center>Easy<br> Hard<br> Crazy
						</td>
					</tr>
				</table>
				</p>
				<p>
					&nbsp;<br>
				</p>
				<p>
				<center>Table 2. Summary of payments</center>

				<table width=80% border=0 class="h40">
					<tr>
						<td width=30% style="border-top: 1px solid">Upfront fee</td>
						<td style="border-top: 1px solid">Free</td>
					</tr>
					<tr>
						<td>Final payment</td>
						<td>$3,000 or up, depends on the protein and the end-use None if failed</td>
					</tr>
					<tr>
						<td>Discount</td>
						<td>30% of the purchasing price of the original AbInsure product</td>
					</tr>
					<tr>
						<td style="border-bottom: 1px solid">Antibodies and cell lines</td>
						<td style="border-bottom: 1px solid">Antibodies: $599 for 1ml, $1,999 for 10ml Cell lines: $1,999 (no IPR) or $3,999 (with IPR)</td>
					</tr>
				</table>
				</p>
				<p>&nbsp;</p>
				<p>We strongly recommend all customers to select re-development option as it is our passion to make sure your antibody will be successful, no matter how hard we will need to try. To encourage this, we give this option the biggest discount/credit among all options.</p>
				<p>&nbsp;</p>
				<div>
					<b>Option 2:</b>

				</div>
				<p>Credit for other purchases: if you decide NOT to continue the failed antibody project, the AbInsure&#8482; will give a credit of 20% of original purchasing price. You are free to use this credit for purchasing any other products or start a new antibody development project. Or simply giving it away to your friends/colleagues for their antibody development or purchasing with us.</p>

<p>&nbsp;</p><p>&nbsp;</p>
			</div>

		</div>

	</div>


</body>
</html>
